Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis
Authors: Michael Linzey, Steven C. Pike, Nour-Maria Bouzid et al.
Publication: Brain, Behavior, and Immunity
Published: Jul 1, 2026
Source: Crossref